<MedlineCitation Status="Completed">
<MedlineID>10011006</MedlineID>
<PMID>420595</PMID>
<DateCreated>
<Year>1979</Year>
<Month>04</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>04</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0003-9942</ISSN>
<JournalIssue>
<Volume>36</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1979</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Oculosympathetic paresis. Analysis of 100 hospitalized patients.</ArticleTitle>
<Pagination>
<MedlinePgn>13-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Of 100 consecutive, adult, hospitalized inpatients with acquired unilateral oculosympathetic palsy, in 63 the central neuron was involved-usually due to strokes; in 21, tumor or trauma affected the preganglionic neuron; and in 13, postganglionic damage was sustained from a variety of causes. The preponderance of first neuron involvement by stroke is in part a reflection of patient sampling, but emphasizes the fact that central causes of Horner's syndrome are common.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Keane</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Arch Neurol</MedlineTA>
<NlmUniqueID>0372436</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>103-86-6</RegistryNumber>
<NameOfSubstance>p-Hydroxyamphetamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Adolescence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Autonomic Fibers, Postganglionic</DescriptorName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Autonomic Fibers, Preganglionic</DescriptorName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Cerebrovascular Disorders</DescriptorName>
<QualifierName>complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Horner Syndrome</DescriptorName>
<QualifierName>diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Middle Age</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Neoplasms</DescriptorName>
<QualifierName>complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Neural Pathways</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Reflex, Pupillary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Sympathetic Nervous System</DescriptorName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Wounds and Injuries</DescriptorName>
<QualifierName>complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>p-Hydroxyamphetamine</DescriptorName>
<QualifierName>diagnostic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
